Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen Daily

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2017
The Toxicity of TimeKaren Daily
Breast Cancer Research and Treatment|July 1, 2020
A case for Tamoxifen with ovarian function suppressionPallavi Kopparthy, Karen Daily
Breast Care (Basel, Switzerland)|November 17, 2025
Outcomes of Breast Cancer Patients by Race and EthnicityRuchi Singhal, Zhanna Galochkina, Karen Daily
BMJ Case Reports|January 18, 2023
Bilateral primary breast Burkitt's lymphoma in pregnancyEllery Altshuler, Sarah Wheeler, Karen Daily
BMJ Case Reports|September 1, 2017
Gemcitabine-induced chronic systemic capillary leak syndromeRavneet Bajwa, Jason Starr, Karen Daily
BMJ Case Reports|April 18, 2023
Systemic absorption of intrathecal methotrexateRuchi Singhal, Karen Daily, Sarah Wheeler
BMJ Case Reports|December 22, 2018
Tumour lysis syndrome following eribulin for metastatic uterine leiomyosarcomaCindy Pabon, Ashwini K Esnakula, Karen Daily
BMJ Case Reports|April 18, 2015
Hepatoid adenocarcinoma of the colonAvan Armaghani, David Hernandez Gonzalo, Karen Daily
BMJ Case Reports|May 4, 2023
Immune-mediated herb-induced liver injury: a potential association with herbal artemisinin use as supported by the updated RUCAMAkash Mathavan, Akshay Mathavan, Urszula Krekora, et al.
Breast Cancer Research and Treatment|November 17, 2021
Does definitive local therapy have a role in select HER2+ de novo metastatic breast cancer patients treated with dual anti-HER2 blockade?Luderve Rosier, Yu Wang, Ji-Hyun Lee, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2017
The Toxicity of TimeKaren Daily
Breast Cancer Research and Treatment|July 1, 2020
A case for Tamoxifen with ovarian function suppressionPallavi Kopparthy, Karen Daily
Breast Care (Basel, Switzerland)|November 17, 2025
Outcomes of Breast Cancer Patients by Race and EthnicityRuchi Singhal, Zhanna Galochkina, Karen Daily
BMJ Case Reports|January 18, 2023
Bilateral primary breast Burkitt's lymphoma in pregnancyEllery Altshuler, Sarah Wheeler, Karen Daily
BMJ Case Reports|September 1, 2017
Gemcitabine-induced chronic systemic capillary leak syndromeRavneet Bajwa, Jason Starr, Karen Daily
BMJ Case Reports|April 18, 2023
Systemic absorption of intrathecal methotrexateRuchi Singhal, Karen Daily, Sarah Wheeler
BMJ Case Reports|December 22, 2018
Tumour lysis syndrome following eribulin for metastatic uterine leiomyosarcomaCindy Pabon, Ashwini K Esnakula, Karen Daily
BMJ Case Reports|April 18, 2015
Hepatoid adenocarcinoma of the colonAvan Armaghani, David Hernandez Gonzalo, Karen Daily
BMJ Case Reports|May 4, 2023
Immune-mediated herb-induced liver injury: a potential association with herbal artemisinin use as supported by the updated RUCAMAkash Mathavan, Akshay Mathavan, Urszula Krekora, et al.
Breast Cancer Research and Treatment|November 17, 2021
Does definitive local therapy have a role in select HER2+ de novo metastatic breast cancer patients treated with dual anti-HER2 blockade?Luderve Rosier, Yu Wang, Ji-Hyun Lee, et al.
Pageof 3